Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-080589
Filing Date
2022-07-18
Accepted
2022-07-18 18:13:35
Documents
1
Period of Report
2022-07-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2221311-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2221311-1_4seq1.xml 4 10341
  Complete submission text file 0001104659-22-080589.txt   11703
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Issuer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMPHASTAR PHARMACEUTICALS INC 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address
Liawatidewi Yakob (Reporting) CIK: 0001743927 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36509 | Film No.: 221090016